Barriers and Facilitators to the Choice of Active Surveillance for Low-Risk Papillary Thyroid Cancer in China: A Qualitative Study Examining Patient Perspectives

被引:13
|
作者
Zhu, Pingting [1 ,2 ]
Zhang, Qianqian [1 ,3 ]
Wu, Qiwei [1 ]
Shi, Guanghui [1 ]
Wang, Wen [1 ]
Xu, Huiwen [1 ]
Zhang, Li [4 ]
Qian, Meiyan [1 ]
Hegarty, Josephine [5 ]
机构
[1] Yangzhou Univ, Sch Nursing & Publ Hlth, Dept Nursing, 136 Jiangyang Middle Rd, Yangzhou 225009, Peoples R China
[2] Jiangsu Key Lab Zoonosis, Yangzhou, Peoples R China
[3] Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesia & Perioperat Med, Nanjing, Peoples R China
[4] Xuzhou Med Univ, Affiliated Hosp 1, Dept Gen Surg, Xuzhou, Peoples R China
[5] Univ Coll Cork, Dept Nursing & Midwifery, Brookfield Hlth Sci Complex, Cork T12 K8AF, Ireland
基金
中国国家自然科学基金;
关键词
papillary thyroid cancer; active surveillance; barriers; facilitators; qualitative study; INFORMATION NEEDS; MANAGEMENT; NODULES; SURGERY; SYSTEM;
D O I
10.1089/thy.2022.0347
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Internationally, several clinical practice guidelines recommend active surveillance as a nonsurgical management strategy for select patients with low-risk papillary thyroid carcinoma. However, patient's decision making when choosing active surveillance as a management approach is not well understood. Thus, our aim was to examine the barriers and facilitators to selecting active surveillance among patients with low-risk papillary thyroid carcinoma in China.Methods: Thirty-nine participants diagnosed with low-risk papillary thyroid carcinoma were purposively recruited between July and November 2021 for semistructured interviews; 24 of whom rejected and 15 patients chose "active surveillance" as a management approach in our sample. Inductive content analysis illustrated emerging themes. Audit trails, member checks, and thematic discussions were used to assert rigor.Results: Barriers and facilitators were classified as patient-related, disease-related, and external factors. Patient-related factors included patient's knowledge, attitudes, and emotions. Disease-related factors included the response to having cancer, the constant state of being diseased, and perceived value of the thyroid gland. External factors included the residual effects of surgery, the active surveillance protocol, and physicians' recommendations.Conclusions: Patient's acceptability of the active surveillance as a management approach are complex with many influencing factors. The public acceptance of active surveillance as a disease management approach needs to be improved, through the presentation of active surveillance as an evidence-based and optimized dynamic management strategy. Clinicians must address their patients' psychological struggles when patients choose active surveillance and patients require more attention and supportive intervention.
引用
收藏
页码:826 / 834
页数:9
相关论文
共 50 条
  • [41] Active surveillance of low-risk papillary thyroid microcarcinomas in Japan and other countries: a review
    Ito, Yasuhiro
    Miyauchi, Akira
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2020, 15 (01) : 5 - 12
  • [42] Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience
    Anabella Smulever
    Fabian Pitoia
    Thyroid Research, 16
  • [43] Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas
    Ito, Yasuhiro
    Oda, Hitomi
    Miyauchi, Akira
    ENDOCRINE JOURNAL, 2016, 63 (04) : 323 - 328
  • [44] Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience
    Smulever, Anabella
    Pitoia, Fabian
    THYROID RESEARCH, 2023, 16 (01)
  • [45] Assessing the Number of Candidates There Are for Active Surveillance of Low-risk Papillary Thyroid Cancers in the US
    Roman, Benjamin R.
    Gupta, Piyush
    Tuttle, R. Michael
    Morris, Luc G. T.
    Lohia, Shivangi
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2020, 146 (06) : 585 - 586
  • [46] Management of Low-Risk Papillary Thyroid Cancer
    Iniguez-Ariza, Nicole M.
    Brito, Juan P.
    ENDOCRINOLOGY AND METABOLISM, 2018, 33 (02) : 185 - 194
  • [47] CHARACTERIZING PATIENT PERSPECTIVES ON FACTORS IMPACTING BEING ON ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER
    Johnson, Shannon
    Hawley, Sarah
    Rankin, Aaron J.
    Skolarus, Ted A.
    Radhakrishnan, Archana
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S236 - S236
  • [48] A protocol for a Canadian prospective observational study of decision-making on active surveillance or surgery for low-risk papillary thyroid cancer
    Sawka, Anna M.
    Ghai, Sangeet
    Tomlinson, George
    Rotstein, Lorne
    Gilbert, Ralph
    Gullane, Patrick
    Pasternak, Jesse
    Brown, Dale
    de Almeida, John
    Irish, Jonathan
    Chepeha, Douglas
    Higgins, Kevin
    Monteiro, Eric
    Jones, Jennifer M.
    Gafni, Amiram
    Goldstein, David P.
    BMJ OPEN, 2018, 8 (04):
  • [49] A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer
    Sawka, Anna M.
    Ghai, Sangeet
    Yoannidis, Tom
    Rotstein, Lorne
    Gullane, Patrick J.
    Gilbert, Ralph W.
    Pasternak, Jesse D.
    Brown, Dale H.
    Eskander, Antoine
    de Almeida, John R.
    Irish, Jonathan C.
    Higgins, Kevin
    Enepekides, Danny J.
    Monteiro, Eric
    Banerjee, Avik
    Shah, Manish
    Gooden, Everton
    Zahedi, Afshan
    Korman, Mark
    Ezzat, Shereen
    Jones, Jennifer M.
    Rac, Valeria E.
    Tomlinson, George
    Stanimirovic, Aleksandra
    Gafni, Amiram
    Baxter, Nancy N.
    Goldstein, David P.
    THYROID, 2020, 30 (07) : 999 - 1007
  • [50] Physician Perspectives of Overdiagnosis and Overtreatment of Low-Risk Papillary Thyroid Cancer in the US
    Dedhia, Priya H.
    Saucke, Megan C.
    Long, Kristin L.
    Doherty, Gerard M.
    Pitt, Susan C.
    JAMA NETWORK OPEN, 2022, 5 (04) : E228722